Osama Hamdy, MD, PhD, medical director of the Joslin Diabetes Center’s Obesity Clinical Program and an associate professor of medicine at Harvard Medical School, both in Boston. He also is coauthor of The Diabetes Breakthrough (Harlequin).
Featured Expert: Osama Hamdy, MD, PhD| January 12, 2026
Reaching or nearing your goal weight is a banner day. But if you were taking a glucagon-like peptide-1 receptor agonist (GLP-1) medication to help with...
Featured Expert: Osama Hamdy, MD, PhD| December 16, 2025
You may have heard that excessive thirst and frequent urination are warning signs of diabetes. That is true, but like so many other chronic conditions,...
Featured Expert: Osama Hamdy, MD, PhD| November 25, 2025
“Ozempic side effects” has become an umbrella term for reactions to all GLP-1 medications. We used to think that there was a slight difference between...